Relypsa, Inc., a Vifor Pharma Group company, is a biopharmaceutical company focused on the discovery, development and commercialization of polymeric medicines for patients with conditions that are often overlooked and undertreated and can be addressed in the gastrointestinal tract. The Company''s first medicine, Veltassa® (patiromer) for oral suspension, was developed based on Relypsa''s rich legacy in polymer science. More information is available at www.relypsa.com.